In fact, glucagon-like peptide 1 drugs such as semaglutide and liraglutide can be effective at curbing alcohol abuse, a study published Wednesday in JAMA Psychiatry suggests. Researchers in Sweden ...
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...
The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says. GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like Jardiance ...
AbbVie said a recently acquired drug candidate for schizophrenia missed the key goal in mid-stage studies, pushing its stock sharply lower. Phase 2 studies for emraclidine failed to show a ...
Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...
doidam10 - stock.adobe.com People who land in the ER for psychedelic use are at significantly higher risk of schizophrenia, according to an eye-opening new study. Canadian researchers tracked more ...
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effectMarks ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning. Credit...Illustration by Armando Veve Supported by By Kim Tingley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback